Tag Archive | "HPV-16"

HPV: To test or not to test

Wednesday, January 5, 2011

0 Comments

Source: www.rdhmag.com Author: Nancy W. Burkhart, RDH, EdD The dental practitioner has a responsibility to examine and assess the oral tissue status of all patients. Usually, we are happy to report that the tissue is healthy and no further treatment is necessary. Ethically, our role in assessment is both an understood practice as well as [...]

Continue reading...

High-risk human papillomavirus in esophageal squamous cell carcinoma

Wednesday, August 11, 2010

0 Comments

Source: cebp.aacrjournals.org Authors: Annika Antonsson et al Background: Although most cases of esophageal squamous cell carcinoma (ESCC) in western populations have been attributed to high levels of exposure to tobacco and alcohol, infectious agents have been postulated as possible causes, particularly human papillomavirus (HPV). Methods: To explore this issue, we analyzed HPV DNA prevalence and [...]

Continue reading...

Human papilloma virus (HPV) and cancer

Saturday, July 31, 2010

0 Comments

Source: ezinearticles.com Author: David Warmflash, MD Human papilloma virus (HPV), is a category of viruses of which more than seventy subtypes are known. Most people have heard of HPV, because the media have spent a good deal of time discussing the issue of mandatory vaccination against the virus. The discussion in the news is well-deserved. [...]

Continue reading...

HPV testing following excisional therapy for cervical neoplasia can identify high-risk patients: presented at IPC

Friday, July 16, 2010

0 Comments

Source: www.docguide.com Author: Louise Gagnon About one-quarter of women continue to have high-risk human papillomavirus (HPV) after excisional therapy for cervical intraepithelial neoplasia (CIN) 2/3, a study presented here at the 26th International Papillomavirus Conference (IPC) has found. Women with CIN are at increased risk for developing invasive cervical cancer, and persistent infection of high-risk [...]

Continue reading...

Immune cells may guide therapy for oropharyngeal cancer

Sunday, May 16, 2010

0 Comments

Source: www.medpagetoday.com Author: Charles Bankhead, Staff Writer, MedPage Today Higher pretreatment levels of cytotoxic T lymphocytes may help identify patients with head and neck cancer who have a favorable prognosis and require less aggressive treatment, according to a study reported here. A higher proportion of CD8 cells predicted improved survival in patients with oropharyngeal cancer [...]

Continue reading...

Needed: HPV vaccine, simple screening test, for women and men

Friday, March 19, 2010

0 Comments

Source: jhu.edu/~gazette Author: Valerie Mehl, Johns Hopkins Medicine A call to explore a broader use of human papillomavirus vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by an investigator at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Leading HPV expert Maura Gillison, [...]

Continue reading...

Oral sex can add to risk of HPV positive cancers

Saturday, March 13, 2010

0 Comments

Source: www.time.com Author: Coco Masters Oral sex can get most men’s attention. The topic becomes considerably more relevant, however, when coupled with a new study linking the human papillomavirus (HPV) to an increased risk of a kind of oral cancer more often seen in men. The study, which appears in this week’s New England Journal [...]

Continue reading...

OralDNA Labs introduces OraRisk HPV salivary diagnostic test

Tuesday, March 2, 2010

0 Comments

Source: www.rdhmag.com Author: press release OralDNA Labs , a leader in advancing wellness in dentistry through salivary diagnostics and a subsidiary of Quest Diagnostics, recently introduced a OraRisk HPV test. The test is a noninvasive, screening tool to identify the type(s) of oral human papillomavirus (also called HPV). Oral HPV is a mucosal viral infection [...]

Continue reading...

New vaccine against HPV approved in Canada

Thursday, February 11, 2010

0 Comments

Source: www.ctv.ca Author: staff Canadian women have a choice of two vaccines against HPV, the family of viruses that can cause cervical cancer, now that Health Canada has approved GlaxoSmithKline’s vaccine, Cervarix. The vaccine, which is expected to be available by the end of the month, will compete against Gardasil, a product of Merck Canada, [...]

Continue reading...

HPV-associated base of tongue squamous cell carcinoma incidence increasing in Sweden

Friday, February 5, 2010

0 Comments

Source: www.hemonctoday.com Author: staff The incidence for base of tongue squamous cell carcinoma increased significantly in Sweden between 1998 and 2007, and by 2007, more than 80% of these cases were HPV-positive. Various studies during the past 20 years have indicated that HPV is a risk factor for oropharyngeal cancer. However, few studies have assessed [...]

Continue reading...